Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma.

Harao, Takuro; Yamada, Ai; Kinoshita, Mariko; Kamimura, Sachiyo; Moritake, Hiroshi

Harao, Takuro; Yamada, Ai; Kinoshita, Mariko; Kamimura, Sachiyo; Moritake, Hiroshi.

Afiliação

Harao T; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Yamada A; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kinoshita M; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Kamimura S; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Moritake H; Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Pediatr Int ; 62(10): 1204-1206, 2020 Oct.

Article em En | MEDLINE | ID: mdl-32989850

Assuntos

Antineoplásicos; Neoplasias Cerebelares; Cisplatino; Perda Auditiva; Meduloblastoma; Antineoplásicos/efeitos adversos; Antineoplásicos/uso terapêutico; Cisplatino/efeitos adversos; Cisplatino/uso terapêutico; Perda Auditiva/induzido quimicamente; Humanos; Meduloblastoma/tratamento farmacológico; Tiossulfatos

Palavras-chave

cisplatin; hearing loss; medulloblastoma; ototoxicity; sodium thiosulfate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Cisplatino / Perda Auditiva / Meduloblastoma / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google